Mindset Pharma Receives Notice of Allowance for Patent Application Covering Psilocin Derivatives for the Treatment of Central Nervous System Disorders

10.06.2022 - TORONTO, June 10, 2022 (GLOBE NEWSWIRE) - Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ('Mindset' or the 'Company'), a drug discovery and development company focused on creating optimized and patentable next-generation psychedelic ...

Related Keywords

Jason Atkinson ,James Lanthier ,Mckenna Miller ,Allison Soss ,Otsuka Pharmaceuticals ,Strategic Communications ,Corporate Development ,Mindset Pharma Inc ,Company Contact ,Strategic Research ,Mcquade Center ,